Socioeconomic risk factors for bacteraemic pneumococcal pneumonia in adults

Epidemiology and Infection

Volumn 137, Issue 5, 2009, Pages 717-726

  Flory, J H ^a   Joffe, M ^a   Fishman, N O ^a   Edelstein, P H ^a   Metlay, J P ^a,b,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Center for Clinical Epidemiology and Biostatistics   (United States)

Author keywords

Disparity; Income; Pneumococcus; Pneumonia; Race

Indexed keywords

ADULT; AFRICAN AMERICAN; AGE; AGED; ANAMNESIS; ARTICLE; ASTHMA; DIABETES MELLITUS; DISEASE SURVEILLANCE; EDUCATIONAL STATUS; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; POVERTY; RACE DIFFERENCE; RISK FACTOR; SMOKING; SOCIOECONOMICS; STREPTOCOCCUS PNEUMONIA; UNITED STATES; ADOLESCENT; BACTEREMIA; ETHNIC GROUP; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PREVALENCE; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTEREMIA; ETHNIC GROUPS; FEMALE; HUMANS; MALE; MIDDLE AGED; PNEUMONIA, PNEUMOCOCCAL; PREVALENCE; RISK FACTORS; SOCIOECONOMIC FACTORS; STREPTOCOCCUS PNEUMONIAE; UNITED STATES; YOUNG ADULT;

EID: 65549088958     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268808001489     Document Type: Article

References (27)

1. Kyaw MH, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. New England Journal of Medicine 2006; 354: 1455-1463.
2. Freed GL, Davis MM, Clark SJ. Variation in public and private supply of pneumococcal conjugate vaccine during a shortage. Journal of the American Medical Association 2003; 289: 575-578.
3. Flannery B, et al. Impact of childhood vaccination on racial disparities in invasive Streptococcus pneumoniae infections. Journal of the American Medical Association 2004; 291: 2197-2203.
4. Anon. Updated recommendations on the use of pneumococcal conjugate vaccine in a setting of vaccine shortage - Advisory Committee on Immunization Practices. Journal of the American Medical Association 2002; 287: 833-834.
5. Butler JC. Epidemiology of pneumococcal disease. In: Tuomanen EI, ed. The Pneumococcus. Washington, DC: ASM Press, 2004, pp. 148-168.
6. HEDIS 2006 Health plan employer data & information set. Vol. 3: Specifications for survey measures. Washington, DC: National Committee for Quality Assurance (NCQA); 2005, p. 248.
7. The Ambulatory Care Quality Alliance Recommended Starter Set. Clinical Performance Measures for Ambulatory Care. Agency for Healthcare Research and Quality. Rockville, MD (http://www.ahrq.gov/qual/ aqastart.htm). Accessed 30 September 2008.
8. Ahmed F, et al. Cost-benefit analysis of a new HEDIS performance measure for penumococcal vaccination. Medical Decision Making 2002; 22: S58-66.
9. Robinson KA, et al. Epidemiology of invasive Streptococcus pneumoniae infections in the United States, 1995-1998: Opportunities for prevention in the conjugate vaccine era. Journal of the American Medical Association 2001; 285: 1729-1735.
10. Davis MM. Race-based immunization recommendations and the potential to reduce health disparities. Journal of the American Medical Association 2004; 291: 2253-2255.
11. American Academy of Pediatrics, Committee on Infectious Diseases. Policy statement: Recommendations for the prevention of pneumococcal infections, including the use of pneumococcal conjugate vaccine (Prevnar), pneumococcal polysaccharide vaccine, and antibiotic prophylaxis. Pediatrics 2000; 106: 362-366.
12. Metlay JP, et al. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine 2006; 24: 468-475.
13. Metlay JP, et al. Macrolide resistance in adults with bacteremic pneumococcal pneumonia. Emerging Infectious Diseases 2006; 12: 1223-1230.
14. Czaja C, Crossette L, Metlay JP. Accuracy of adult reported pneumococcal vaccination status of children. Annals of Epidemiology 2005; 15: 253-256.
15. United States Census 2000. Washington, DC: US Census Bureau, 2005 (http://www.census.gov/main/www/cen2000.html). Accessed 1 December 2005.
16. Ruggles S, et al. Integrated Public Use Microdata Series: Version 3.0 [Machine-readable database]. Minneapolis, MN: Minnesota Population Center; 2004 (http://www.ipums.org). Accessed 1 December 2005.
17. Southeastern Pennsylvania Household Health Survey. Philadelphia, PA: Philadelphia Health Management Corporation, 2004.
18. SAS Online Documentation (http://support.sas.com/documentation/ onlinedoc/91pdf/sasdoc_913/whatsnew_10878.pdf). Accessed 5 September 2008.
19. Kenward MG, Carpenter J. Multiple imputation: Current perspectives. Statistical Methods in Medical Research 2007; 16 199-218.
20. Allison, PD. Missing Data. Thousand Oaks, CA: Sage Publications, 2002.
21. Rothman K. Modern Epidemiology, 2nd edn. Lippincott Williams & Wilkins, 1998.
22. Chen FM, et al. Geocoding and linking data from population-based surveillance and the US Census to evaluate the impact of median household income on the epidemiology of invasive Streptococcus pneumoniae infections. American Journal of Epidemiology 1998; 148: 1212-1218.
23. Talbot TR, et al. Asthma as a risk factor for invasive pneumococcal disease. New England Journal of Medicine 2005; 352 2082-2090.
24. Thomsen RW, et al. Risk of community-acquired pneumococcal bacteremia in patients with diabetes. Diabetes Care 2004; 27 1143-1147.
25. Nuorti JP, et al. Cigarette smoking and invasive pneumococcal disease. New England Journal of Medicine 2000; 342 681-689.
26. ACIP. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recommended Reports 1997; 46(RR-8): 1-24.
27. Shariatzadeh MR, et al. Bacteremic pneumococcal pneumonia: A prospective study in Edmonton and neighboring municipalities. Medicine (Baltimore) 2005; 84: 147-161.